- Report
- February 2024
- 80 Pages
Japan
From €1481EUR$1,500USD£1,237GBP
- Report
- February 2024
- 80 Pages
Ireland
From €1481EUR$1,500USD£1,237GBP
- Report
- February 2024
- 80 Pages
Germany
From €1481EUR$1,500USD£1,237GBP
- Report
- February 2024
- 80 Pages
France
From €1481EUR$1,500USD£1,237GBP
- Report
- February 2024
- 80 Pages
China
From €1481EUR$1,500USD£1,237GBP
- Report
- February 2024
- 80 Pages
Brazil
From €1481EUR$1,500USD£1,237GBP
- Report
- February 2024
- 80 Pages
Argentina
From €1481EUR$1,500USD£1,237GBP
- Report
- January 2024
- 80 Pages
Poland
From €1481EUR$1,500USD£1,237GBP
- Report
- January 2024
- 80 Pages
Argentina
From €1481EUR$1,500USD£1,237GBP
- Report
- December 2023
- 100 Pages
Africa
From €1975EUR$2,000USD£1,649GBP
- Report
- December 2023
- 80 Pages
Brazil
From €1481EUR$1,500USD£1,237GBP
- Report
- December 2023
- 80 Pages
China
From €1481EUR$1,500USD£1,237GBP
- Report
- December 2023
- 80 Pages
France
From €1481EUR$1,500USD£1,237GBP
- Report
- December 2023
- 80 Pages
Germany
From €1481EUR$1,500USD£1,237GBP
- Report
- December 2023
- 80 Pages
Ireland
From €1481EUR$1,500USD£1,237GBP
- Report
- December 2023
- 80 Pages
Japan
From €1481EUR$1,500USD£1,237GBP
- Report
- December 2023
- 80 Pages
Russia
From €1481EUR$1,500USD£1,237GBP
- Report
- December 2023
- 80 Pages
Vietnam
From €1481EUR$1,500USD£1,237GBP
- Report
- October 2023
- 80 Pages
Russia
From €1481EUR$1,500USD£1,237GBP
- Report
- October 2023
- 80 Pages
Ireland
From €1481EUR$1,500USD£1,237GBP
The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more